Haemodialysis vascular access is a 'lifeline' for almost 2 million patients worldwide; yet given the substantial problems associated with access dysfunction, vascular access is also the Achilles heel ...
Dialysis access requires frequent cannulation, often exceeding 300 needle punctures annually - - The ATEV was observed to maintain long-term ...
(HealthDay)—A percutaneous arteriovenous fistula (pAVF) created by an interventionalist in the office-based lab provides durable access for hemodialysis through five years, according to a study ...
San Juan Capistrano, Calif.--Two devices for creating minimally invasive dialysis access--the Ellipsys® Vascular Access System and the WavelinQâ„¢ 4F System--demonstrated high rates of technical success ...
NEW ORLEANS — With the help of nanotechnology, interventionalists might soon be able to create an immediate and permanent percutaneous arteriovenous fistula that has patency and maturation rates ...
A new study shows that for those individuals with chronic kidney disease, it doesn't matter if you're young or old: arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's ...
KUALA LUMPUR, 10 April 2026 – Maaedicare Charitable Foundation has achieved a remarkable milestone today, becoming Malaysia’s first dialysis provider to implement ultrasound-guided cannulation across ...
Still, approximately 70% of patients initiate dialysis with a catheter. Arteriovenous fistula (AVF) use increased from 24% in 1997 to 68% in 2013 in the U.S. hemodialysis (HD) population a new study ...
An arteriovenous (AV) fistula connects an artery to a vein in your arm. This provides a stronger access point for the needles from a hemodialysis machine. If you have end stage kidney disease (ESKD), ...
To determine whether the lower rate of fistula use among obese patients is caused by reduced rates of fistula creation, or by elevated rates of primary or secondary fistula failure. Design and ...
- The ATEV was observed to maintain long-term structural integrity and self-repair with smooth muscle cell repopulation despite repeated cannulations - - Humacyte anticipates that top-line interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results